Phase II Study of Oxaliplatin and Navelbine for Second-Line Treatment of Advanced NSCLC.

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2005 by Integrated Community Oncology Network.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborator:
Sanofi
Information provided by:
Integrated Community Oncology Network
ClinicalTrials.gov Identifier:
NCT00238849
First received: October 12, 2005
Last updated: October 13, 2005
Last verified: October 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given